InfuSystem Holdings (INFU) Liabilities and Shareholders Equity (2010 - 2026)

InfuSystem Holdings (INFU) posted Liabilities and Shareholders Equity of $98.7 million for Q1 2026, down 1.89% on a QoQ basis from $100.6 million in Q4 2025, and down 5.39% year-over-year from $104.3 million in Q1 2025.

InfuSystem Holdings (INFU) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

InfuSystem Holdings' Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $98.7 million for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 5.39% year-over-year to $98.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $398.9 million (down 5.4% YoY) and the FY2025 annual result came in at $100.6 million, down 2.95% from the prior year.
  • Liabilities and Shareholders Equity was $98.7 million for Q1 2026 at InfuSystem Holdings, down from $100.6 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $108.5 million in Q2 2024 and bottomed at $98.2 million in Q1 2022.
  • A 5-year average of $101.8 million and a median of $102.1 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity grew 8.44% — and 2025, when it dropped 7.07%.
  • InfuSystem Holdings' Liabilities and Shareholders Equity stood at $99.4 million in 2022, then rose by 3.55% to $102.9 million in 2023, then climbed by 0.68% to $103.6 million in 2024, then fell by 2.95% to $100.6 million in 2025, then dropped by 1.89% to $98.7 million in 2026.
  • Business Quant data shows INFU's Liabilities and Shareholders Equity at $98.7 million in Q1 2026, $100.6 million in Q4 2025, and $98.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 InfuSystem Holdings 179.47 Mn 177.37 Mn 19.68 Mn 98.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 98.66 Mn
Dec 31, 2025 100.56 Mn
Sep 30, 2025 98.88 Mn
Jun 30, 2025 100.85 Mn
Mar 31, 2025 104.28 Mn
Dec 31, 2024 103.61 Mn
Sep 30, 2024 105.30 Mn
Jun 30, 2024 108.53 Mn
Mar 31, 2024 104.85 Mn
Dec 31, 2023 102.92 Mn
Sep 30, 2023 102.07 Mn
Jun 30, 2023 102.75 Mn
Mar 31, 2023 102.26 Mn
Dec 31, 2022 99.39 Mn
Sep 30, 2022 98.98 Mn
Jun 30, 2022 98.82 Mn
Mar 31, 2022 98.24 Mn
Dec 31, 2021 97.59 Mn
Sep 30, 2021 94.79 Mn
Jun 30, 2021 96.00 Mn